Joseph Perekupka

About

CEO with 20+ years building and scaling healthcare and MedTech companies, specializing in commercialization, reimbursement strategy, and enterprise turnaround. Proven leader in capital formation, board collaboration, and transforming emerging technologies into scalable, profitable businesses; led multiple revenue growth initiatives, secured CMS reimbursement pathway (unique HCPCS code/category), and built executive teams with full P&L ownership.

Experience

• Board Director · Freespira, Inc.06-01-2022

  ● Transformed the enterprise to successfully address challenges in strategy, reimbursement, and commercialization. ● Developed and instituted a consistent method for measuring success and accountability using KPI’s. ● Delivered consecutive years of revenue growth while maintaining net‑zero headcount increases, significantly improving capital efficiency and operating leverage. ● Led successful $10MM financing round (2024) in a constrained capital markets environment, extending runway and positioning the company for its next phase of growth. ● Secured a unique CMS HCPCS code and reimbursement category for a novel behavioral health treatment, creating a durable and differentiated reimbursement pathway. ● Designed and launched innovative at‑risk reimbursement models with VA, Medicaid, and commercial payers, generating new and predictable revenue streams. ● Built and led the executive team overseeing operations, finance, commercialization, reimbursement, and analytics with full P&L ownership. ● Implemented enterprise‑wide data analytics and KPI frameworks to improve decision‑making, performance management, and board reporting.

• Chief Executive Officer · Freespira, Inc.06-01-2022 – 2026

  ● Transformed the enterprise to successfully address challenges in strategy, reimbursement, and commercialization. ● Developed and instituted a consistent method for measuring success and accountability using KPI’s. ● Delivered consecutive years of revenue growth while maintaining net‑zero headcount increases, significantly improving capital efficiency and operating leverage. ● Led successful $10MM financing round (2024) in a constrained capital markets environment, extending runway and positioning the company for its next phase of growth. ● Secured a unique CMS HCPCS code and reimbursement category for a novel behavioral health treatment, creating a durable and differentiated reimbursement pathway. ● Designed and launched innovative at‑risk reimbursement models with VA, Medicaid, and commercial payers, generating new and predictable revenue streams. ● Built and led the executive team overseeing operations, finance, commercialization, reimbursement, and analytics with full P&L ownership. ● Implemented enterprise‑wide data analytics and KPI frameworks to improve decision‑making, performance management, and board reporting.

• Chief Commercial Officer · Eversana07-01-2021 – 06-01-2022

  Digital Therapeutic Division– MedRhythms Complete Commercialization Program ● Operated as the commercial lead for a pre-FDA cleared digital therapeutic focused on neurological disorders. ● Created the go-to-market strategy and forecasted revenue growth from launch through five years. ● Drove preparedness for FDA submission, including labeling, product description, pre-launch payor engagement, and evidence generation plan. ● Formulated appropriate hiring timelines for the field force team, including MSLs, payer sales specialists, sales management, and field sales. ● Leveraged relationships with key payers to develop a lucrative payer/market access strategy.

• Chief Commercial Officer · Freespira, Inc.08-01-2019 – 07-01-2021

  ● Developed and executed new strategies for commercial and government markets, resulting in 30% YOY revenue growth. ● Hired and led sales, market access, and customer success teams; restructured departments to ensure successful cross-functional collaboration and execution of objectives. ● Introduced a sales cycle and management workflow that created better transparency across all divisions. ● Re-engineered the patient journey workflow for efficiency and an enhanced experience, improving retention, outcomes, and satisfaction. ● Developed specific messaging platforms for payers, employers, government, and MBHOs. ● Shared key insights about company performance during quarterly board meetings.

• SVP/GM of North America · BrainsWay, Ltd09-01-2015 – 08-01-2019

  Neuromodulation Medical Device Manufacturer ● Led the company from initial commercial launch through a successful IPO, created a U.S. subsidiary organization, and developed go-to-market and reimbursement strategies. ● Served as GM with P&L responsibility for all North American sales, strategic planning, marketing, operations, and customer service. ● Realized U.S. Business unit profitability within one year, captured 20% of market share in a new product launch, and grew revenue by 147% to achieve market leader status within two years. ● Increased warranty revenue by 200% and offset incremental clinical team costs with innovative department restructuring. ● Spearheaded the rebranding initiative from ideation to website launch. ● Reduced customer attrition by designing an algorithm to identify the optimal point for support staff addition. ● Created a program to monitor product malfunctions, recurring issues, and costs associated with service issues.

• Director of National Accounts/Field Marketing · Biotronik, Inc.10-01-2014 – 09-01-2015

  Cardiology Medical Device Manufacturer ● Created a new marketing program for clinicians promoting unique benefits ● Expanded company footprint by 30% with leveraged contract programs

• Sr. Regional Sales Director · St. Jude Medical, Inc.06-01-2005 – 10-01-2014

  Cardiology Medical Device Manufacturer ● Progressively promoted to positions of greater responsibility, ultimately managing all Territory Managers and Field Sales Reps; increased revenue generation from $30 million to $45 million over five years.

• Strategic Advisor · Neuvotion, Inc.04-01-2026

  Neuromodulation Medical Device Manufacturer ● Developing a commercial strategy for a novel stroke/spinal cord injury neurostimulation and AI platform.

• Strategic Advisor · Sooma10-01-2024

  Neuropsychiatry Medical Device Manufacturer ● Guiding the regulatory and reimbursement pathways for a non-invasive (tDCS) device for depression and chronic pain.

Education

• Fordham University Gabelli School of ManagementMBA Degree in Management and Finance, Management and Finance
• Pennsylvania State UniversityBachelor of Science in Marketing, Business Law, Marketing, Business Law

Similar talent on Pangea

Michelle R.Healthcare SaaS & Digital Health Executive | VP Strategic Accounts | Leading & Scaling High Performing Teams Across Client Success, Commercialization & Care Operations | Health Plans, Employers, ProvidersUnited StatesBen B.Senior Marketing Manager Driving Strategic Market Development in HealthcareSeattle, WALaura I.Healthcare Policy | Strategy and Operations| Program Development | Process Improvement | Governance Risk ComplianceLudovico R.CEO @ Medisure (Healthtech) | Clinical Data & Strategy Consultant | Open to Fractional & Advisory Roles | Forbes U30Turin, Metropolitan City of Turin